François R Girardin

Has grant

Associate Professor of medicine and clinical Pharmacology

Lausanne University Hospital

Switzerland

Research Interests

Explore related searches

Professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

François R Girardin is an Associate Professor of Medicine and Clinical Pharmacology at Lausanne University Hospital and the University of Lausanne in Switzerland. His research interests focus on therapeutic drug monitoring, precision dosing, and pharmacogenomics, as evidenced by his recent publications on Janus kinase inhibitors and the influence of CYP2D6 genotypes on clinical responses. He is also involved in studies related to cytomegalovirus infection post-transplantation and the pharmacokinetics of various medications, emphasizing the importance of individualizing drug therapy.

Recent Grants

Grant: Close

Onco-PoK2 a MEM-TDM-nanosensor for imatinib

Open Date: 2023-11-01

Close Date: 2025-06-01

Grant: Close

EU-TRAIN: the EUropean Transplantation and Innovation consortium for risk stratification in kidney transplant patients

Open Date: 2019-01-01

Close Date: 2024-06-01

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (10)

Joachim Marti

University of Lausanne

SWITZERLAND

View details

marco solmi

Associate Professor

University of Ottawa

CANADA

View details

Alessandro Ceschi

Professor

University of Applied Sciences of Southern Switzerland

SWITZERLAND

View details

Kim Dao

SWITZERLAND

View details

Benoit Guery

Associate Professor

Lausanne University Hospital

SWITZERLAND

View details

Elena Tessitore

SWITZERLAND

View details

Elena Crespo

Vall d'Hebron Institut de Recerca

SPAIN

View details

Catia Marzolini

University Hospital Basel

SWITZERLAND

View details

Cédric Follonier

University Hospital of Geneva

SWITZERLAND

View details

Laurent Decosterd

Head of the Laboratory of Clinical Pharmacology / Associated Professor

Centre Hospitalier Universitaire Vaudois

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

François R Girardin

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

Therapeutic Drug Monitoring for Precision Dosing of Janus Kinase Inhibitors: Protocol for a Prospective Observational Study

Influence of CYP2D6 Genotypes and Phenotypes on the Plasma Levels and Clinical Response to Aripiprazole.

A New Prognostic Score Based on Cell-Mediated Immunity for Cytomegalovirus Infection After Transplantation

Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis

A Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Cystic Fibrosis Drugs (Caftors) in Plasma and Its Application for Therapeutic Monitoring

Individualization of piperacillin dosage based on therapeutic drug monitoring with or without model-informed precision dosing: a scenario analysis

Tératovigilance. Anticonvulsivants durant la grossesse et lors de prise paternelle

Highly sensitive ultra-high-performance liquid chromatography coupled with tandem mass spectrometry method for the multiplex analysis of levosimendan and its metabolites OR-1855 and OR-1896 in human plasma

Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIV

Importance of sex-dependent differences for dosing selection and optimization of chemotherapeutic drugs

Four cases of audio-vestibular disorders related to immunisation with SARS-CoV-2 mRNA vaccines

Antidepressants and the risk of bleeding in the era of anti-amyloid drugs.

Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment.

Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN).

Cardiovascular therapy use, modification, and in-hospital death in patients with COVID-19: A cohort study.

Pharmacogenomic-guided clozapine administration based on HLA-DQB1, HLA-B and SLCO1B3-SLCO1B7 variants: an effectiveness and cost-effectiveness analysis

Evaluating the risk of drug-drug interactions with pharmacokinetic boosters: the case of ritonavir-enhanced nirmatrelvir to prevent severe COVID-19

Scaling-up hepatitis C screening and treatment in Swiss outpatient psychiatric settings: A cost-effectiveness analysis

Inhibiteurs des Janus kinases : nouvelles perspectives pour la médecine de précision ?

Hepatitis C prevalences in the psychiatric setting: Cost-effectiveness of scaling-up screening and direct-acting antiviral therapy

Collaborators (10)

Joachim Marti

marco solmi

Alessandro Ceschi

Kim Dao

Benoit Guery

Elena Tessitore

Elena Crespo

Catia Marzolini

Cédric Follonier

Laurent Decosterd

Make your next move.